Linoleic acid metabolites in health and disease.
Buchanan
M R
MR
Department of Pathology, McMaster University, Hamilton, Ontario.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D002450:Cell Communication; D004041:Dietary Fats / Q000008:administration & dosage; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism / Q000494:pharmacology; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control; D019787:Linoleic Acid / Q000378:metabolism*; D008041:Linoleic Acids / Q000378:metabolism / Q000494:pharmacology; D009362:Neoplasm Metastasis; D051381:Rats; D017208:Rats, Wistar; D013927:Thrombosis / Q000378:metabolism / Q000517:prevention & control
D004041:Dietary Fats; D006893:Hydroxyeicosatetraenoic Acids; D008041:Linoleic Acids; C024348:13-hydroxy-9,11-octadecadienoic acid; D019787:Linoleic Acid; D011464:Epoprostenol